ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2193

Prevalence of Raynaud’s Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry’s Disease: A Cross-Sectional Study

Samuel Deshayes1, Roland Jaussaud2, Bernard Imbert3, Olivier Lidove4, Jean-Jacques Parienti5, Nathalie Triclin6, Laurent Auboire7 and Boris Bienvenu1, 1Médecine interne, CHU Côte de Nacre, CAEN, France, 2Médecine interne, maladies infectieuses, immunologie clinique, CHU de Reims, REIMS, France, 3CHU, Grenoble, Grenoble, France, 4Médecine interne, Hôpital Croix-Saint-Simon, PARIS, France, 5Biostatistiques, CHU Côte de Nacre, CAEN, France, 6Association des Patients de la Maladie de Fabry, VENDRESSE, France, 7Inserm U930, UMR Imagerie et Cerveau, TOURS, France

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Raynaud's phenomenon and capillaroscopy

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases

Session Type: Abstract Submissions (ACR)

Background/Purpose: Fabry’s disease (FD) is a lysosomal disorder leading to progressive systemic involvement, including neurologic and vascular. We hypothesize that the microangiopathy observed in FD could be documented, including at an early stage, by using nailfold capillaroscopy and assessing the presence of Raynaud’s phenomenon (RP). The objective of this study was to measure the prevalence of RP and nailfold capillaroscopic abnormalities in FD.

Methods: This cross-sectional study included a standardized questionnaire and a nailfold capillaroscopy assessing previous reported patterns in FD (dystrophic and giant capillaries, avascular fields, irregular architecture, dilatation and density of capillaries, hemorrhage), and was conducted on 32 Fabry patients and 39 controls. Two independent blinded reviewers carried out the analysis of capillaroscopic photographs.

Results:

Table 1 : Demographic and clinical characteristics of Fabry patients and controls

Fabry patients Control group p value
n 32 39
Age, mean ± SD 45,5 ± 13,8 48,2 ± 11,5 0.38
Sex-ratio (males/females) 0,46 (10/22) 1,6 (24/15) 0.02
Smoking, n (%) 1 (3) 4 (10) 0.37

Cannabis, n (%)

0 (0) 0 (0) 1
Hypertension, n (%) 8 (25) 4 (10) 0.1
Hyperlipidemia, n (%) 4 (13) 4 (10) 1
Diabetes, n (%) 1 (3) 3 (8) 0.63
Pain in the extremities, n (%) 28 (88) 0 (0) <0.001
Enzyme replacement therapy, n (%) 25 (78) 0 (0) <0.001

Table 2 : Characteristics of patients suffering from Raynaud’s phenomenon (RP)

Fabry patients Control group p value
Males with RP, n (%) 5/10 (50) 0/24 (0) <0.001
Females with RP, n (%) 7/22 (32) 2/15 (13) 0.27
Total with RP, n (%) 12/32 (38) 2/39 (5) <0.001

Patients with FD and RP all suffered from pain in the extremities, whereas none in the control group did (p = 0.011). RP was concomitant or prior to the occurrence of pain in the extremities in 42% of Fabry patients. Significantly more ramified capillaries were observed in Fabry patients (12/32, 38%) than in controls (5/39, 15%, p = 0.016). No other statistically significant difference was observed by nailfold capillaroscopy.

Conclusion: This study is, to the best of our knowledge, the largest one assessing nailfold capillaroscopy and the presence of RP in FD. RP was highly prevalent in our series of Fabry patients (38%) and involved 50% of males. FD should thus be considered as a cause of secondary RP. RP was concomitant or prior to the occurrence of pain in the extremities in almost 50% of Fabry patients. It could be, at least in part, a causal factor of these pains. Secondary RP should lead to a screening for FD, especially in men. By extension, in high-risk populations (i.e. hypertrophic cardiomyopathy, dialysis patients, stroke in young people), the presence of ramified capillaries and RP should also be assessed.


Disclosure:

S. Deshayes,

Genzyme Corporation,

9;

R. Jaussaud,

SHIRE,

6,

Genzyme Corporation,

6;

B. Imbert,
None;

O. Lidove,

SHIRE,

6,

Genzyme Corporation,

6;

J. J. Parienti,
None;

N. Triclin,
None;

L. Auboire,
None;

B. Bienvenu,

Genzyme Corporation,

6,

Shire,

6.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2014

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-raynauds-phenomenon-and-nailfold-capillaroscopic-abnormalities-in-fabrys-disease-a-cross-sectional-study/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology